Quetiapine 100 mg Sr Tab.
Meritino 100 sr
Quetiapine fumarate sustained-release tablets are a type of medication used to treat various mental health conditions, primarily schizophrenia and bipolar disorder. The tablets contain quetiapine fumarate as the active ingredient. Quetiapine is a type of medicine called atypical antipsychotics.
The sustained-release formulation means that the medication is designed to release the active ingredient slowly over an extended period in the body, providing a consistent level of the drug throughout the day. This can help maintain therapeutic levels and improve convenience by reducing the frequency of dosing.
The 100 mg strength refers to the amount of quetiapine fumarate present in each tablet. The tablets may come in different shapes, sizes, and colors, depending on the manufacturer or brand. They are typically taken orally, usually once daily with or without food, as directed by a healthcare professional.
Quetiapine works by acting on certain neurotransmitters in the brain, such as dopamine and serotonin. It helps to restore the balance of these chemicals, which can alleviate symptoms associated with schizophrenia and bipolar disorder, including hallucinations, delusions, mood swings, and disorganized thinking.
When formulated as sustained-release tablets, quetiapine fumarate offers several benefits:
Treatment of mental disorders: Quetiapine fumarate sustained-release tablets are primarily used to treat various mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder.
Extended-release: The sustained-release formulation allows for a slow and controlled release of the medication into the bloodstream over an extended period. This means that the therapeutic effects of quetiapine fumarate are maintained throughout the day, reducing the need for multiple doses.
Improved adherence: With the sustained-release formulation, patients typically need to take quetiapine fumarate only once daily. This simplifies the dosing regimen and increases treatment adherence, as patients may find it easier to remember and comply with their medication schedule.
Stabilizes mood: Quetiapine fumarate has mood-stabilizing properties, making it effective in managing the manic and depressive episodes associated with bipolar disorder. It helps regulate neurotransmitters in the brain, including dopamine and serotonin, which play important roles in mood regulation.
Sleep aid: Quetiapine fumarate can have sedative effects, especially at lower doses. This makes it useful for treating sleep disturbances associated with certain mental disorders. It can help improve sleep quality and reduce insomnia, promoting better overall well-being.
Adjunctive therapy: Quetiapine fumarate sustained-release tablets can be used as an adjunctive therapy alongside other medications for conditions like major depressive disorder. It can enhance the effectiveness of antidepressants and improve treatment outcomes.
Tolerability: Quetiapine fumarate is generally well-tolerated, and the sustained-release formulation may help minimize certain side effects commonly associated with immediate-release formulations.
Quetiapine Fumarate Sustained-Release Tablets may cause some common side effects, including drowsiness, dizziness, dry mouth, constipation, and weight gain.
Other side effects may occur less frequently, such as headache, blurred vision, increased heart rate, and low blood pressure upon standing.